PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1608860
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1608860
De-identified health data market is estimated to be valued at USD 7.51 Bn in 2024 and is expected to reach USD 13.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | 7.51 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 9.10% | 2031 Value Projection: | 13.80 Bn |
De-identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De-identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de-identified data available for secondary usage.
Rising focus on value-based care, personalization of treatment, and growth of digital health startups can boost demand for de-identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health-related datasets to encourage transparency and innovation in public health research.
Key features of the study
This report provides in-depth analysis of the global de-identified health data market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global de-identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global de-identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global de-identified health data market